Core Insights - Royal Philips has introduced DeviceGuide, an AI-powered device tracking solution designed to assist physicians during minimally invasive heart valve repair procedures, enhancing clarity and confidence in navigating the beating heart [1][2][5]. Company Overview - Royal Philips is a global leader in health technology, focusing on improving health and well-being through innovation, with a strong emphasis on patient-centric solutions [12][13]. - The company generated sales of EUR 18 billion in 2024 and employs approximately 67,000 people across more than 100 countries [13]. Product Details - DeviceGuide is built on Philips' EchoNavigator platform and utilizes AI to provide real-time visual guidance during interventional cardiology procedures, specifically for repairing leaking mitral valves [1][4]. - The solution combines live echo and X-ray images to create a virtual 3D model of the treatment device, allowing clinicians to see its position and orientation within the heart [5][6]. Clinical Impact - Mitral valve regurgitation affects over 35 million adults globally, leading to symptoms such as shortness of breath and fatigue, and can result in severe complications if untreated [2][3]. - DeviceGuide aims to assist physicians in performing transcatheter edge-to-edge repair (M-TEER) procedures, which are vital for patients who are not suitable candidates for open-heart surgery [3][4]. Collaboration - The development of DeviceGuide involved collaboration with Edwards Lifesciences, integrating Philips' imaging and AI expertise with Edwards' leadership in structural heart innovation [6][10]. Future Outlook - The introduction of DeviceGuide exemplifies the potential of combining advanced imaging and therapy expertise to innovate procedural workflows, setting a precedent for future AI-enabled, image-guided interventions [7][10].